| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |